Skip to main content

Table 2 The general information of rats in each group before cells treatment (X ± S)

From: Therapeutic effect of integrin-linked kinase gene-modified bone marrow-derived mesenchymal stem cells for streptozotocin-induced diabetic cystopathy in a rat model

Time point

Control

DM

BMSCs

Ad-null-BMSCs

Ad-ILK-BMSCs

Body weight (g)

 Before modeling

189 ± 11.7

178 ± 12.5

171 ± 8.6

184 ± 10.9

176 ± 9.6

 10th week

394 ± 18.1

167 ± 20.4

163 ± 15.9

164 ± 13.7

159 ± 18.5

 14th week

503 ± 37.2

162 ± 26.8

160 ± 27.8

162 ± 19.1

157 ± 24.1

Blood glucose level (mM)

 First week

4.7 ± 0.68

22.5 ± 3.8

22.9 ± 4.9

21.8 ± 4.1

23.6 ± 3.6

 14th week

5.1 ± 0.41

24.1 ± 4.2

23.8 ± 3.3

23.1 ± 4.7

22.8 ± 4.8

  1. S standard deviation, X X-bar